Cambridge Cognition (COG) PT Lowered to GBX 155 at FinnCap

Cambridge Cognition (LON:COG) had its price objective cut by FinnCap from GBX 180 ($2.44) to GBX 155 ($2.10) in a report released on Wednesday. They currently have a corporate rating on the stock.

Shares of Cambridge Cognition (LON:COG) traded up GBX 8.50 ($0.12) during mid-day trading on Wednesday, hitting GBX 129.50 ($1.76). 70,053 shares of the stock were exchanged, compared to its average volume of 8,362. Cambridge Cognition has a twelve month low of GBX 68.20 ($0.92) and a twelve month high of GBX 169 ($2.29).

TRADEMARK VIOLATION WARNING: “Cambridge Cognition (COG) PT Lowered to GBX 155 at FinnCap” was originally reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at

About Cambridge Cognition

Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company’s segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials.

Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit